ArticleVirology journal2024
Epidemiological characteristics of respiratory pathogens infections among children after the removal of non-pharmaceutical interventions in central China.
Article in Virology journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The prevalence and role of human respiratory syncytial virus in pediatric respiratory tract infections: a systematic review and meta-analysis of global data.EClinicalMedicine · 2026Article
- Interaction analysis of non-bacterial respiratory pathogens during and after the coronavirus disease 2019 pandemic in two cities along the eastern coast of China.Pediatric investigation · 2026Article
- Epidemiology of acute respiratory infections in children in Pudong, Shanghai: analysis of seven respiratory test results from 2018 to 2023.Virology journal · 2026Article
- Comparative epidemiology of six respiratory pathogens among children aged 28 days to 14 years with acute respiratory infections in coastal Xiamen and inland Linxia, China: a multicenter retrospective study.Frontiers in public health · 2026Article
- Epidemiological characteristics of bacterial lower respiratory tract infections in Jingzhou, Central China, 2020-2024.Frontiers in cellular and infection microbiology · 2026Article
- Pathogen profiles and co-detection characteristics of acute respiratory infections based on active surveillance in a large district of southern China.Frontiers in public health · 2026Article
- Co-Detection of ADV, Influenza B, and HPIV: Independent Risk Factors for SMPP with Changes in NPIs.Viruses · 2025Article
- hMPV Outbreaks: Worldwide Implications of a Re-Emerging Respiratory Pathogen.Microorganisms · 2025Review
- Epidemiology of respiratory infections during the different levels of non-pharmaceutical interventions.BMC pediatrics · 2025Article
- The prevalence trends of Trichomonas vaginalis infection among women in Jingzhou, central of China, 2019-2023.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDuring the COVID-19 pandemic between 2020 and 2022 in China, various non-pharmaceutical interventions (NPIs) were implemented to reduce the spread of SARS-CoV-2 and other respiratory pathogens. From 2023, China downgraded the management of COVID-19, and compliance with NPIs was no longer mandatory. This study aimed to reveal the epidemiological characteristics of respiratory pathogens in 2023 after the removal of NPIs in central China.
methodsRespiratory specimens of children with acute respiratory infections (ARIs) were obtained to detect seven common respiratory pathogens, including influenza A (FluA), influenza B (FluB), adenovirus (ADV), human rhinovirus (HRV), human respiratory syncytial virus (HRSV), human metapneumovirus (HMPV), Mycoplasma pneumoniae (MP). From January 2022 to December 2023, a total of 5423 specimens were collected, including 1122 children in 2022 and 4301 children in 2023.
resultsOne or more pathogens were detected in 62.50% specimens in 2023, significantly higher than that in 2022 (44.12%). HRV (13.81%) was the most common pathogen in 2022, whereas MP (24.67%) was predominant in 2023. There was no significant difference in the overall prevalence of HRV, HRSV and HMPV between 2022 and 2023. HRSV was the most common pathogen in the < 1 years children both in 2022 and 2023. However in the ≥ 7 years group, FluB was the predominant pathogen in 2022 whereas MP ranked first in 2023. Co-detection were significantly more frequent in 2023 compared to 2022.
conclusionsThe removal of NPIs significantly increased the infection rates of the respiratory pathogens among children. Some NPIs, such as wearing mask and hand hygiene are necessary to decrease the prevalence of certain pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.